The Journal of Korean Diabetes

Search

Page Path

HOME
Search

Statement

당뇨병 환자에서 심혈관질환 위험도 평가: 김진화; J Korean Diabetes. 2021;22(3):168-173. Published online September 30, 2021; DOI: https://doi.org/10.4093/jkd.2021.22.3.168

Focused Issues

Glucagon-Like Peptide 1 수용체작용제 최신지견: 김혜진; J Korean Diabetes. 2021;22(2):126-133. Published online June 30, 2021; DOI: https://doi.org/10.4093/jkd.2021.22.2.126

Sodium Glucose Cotransporter-2 억제제의 최신지견: 조동혁; J Korean Diabetes. 2021;22(2):113-125. Published online June 30, 2021; DOI: https://doi.org/10.4093/jkd.2021.22.2.113

설포닐유레아 최신지견: 김태년; J Korean Diabetes. 2021;22(2):105-112. Published online June 30, 2021; DOI: https://doi.org/10.4093/jkd.2021.22.2.105

메트포민의 최신지견: 홍상모; J Korean Diabetes. 2021;22(2):85-90. Published online June 30, 2021; DOI: https://doi.org/10.4093/jkd.2021.22.2.85

임신성 당뇨병의 심혈관계 위험도: 김경수; J Korean Diabetes. 2020;21(2):75-80. Published online June 2, 2020; DOI: https://doi.org/10.4093/jkd.2020.21.2.75

노인 당뇨병 환자의 심혈관질환 위험인자 관리: Sung Hoon Yu; J Korean Diabetes. 2019;20(4):233-238. Published online January 17, 2020; DOI: https://doi.org/10.4093/jkd.2019.20.4.233

당뇨병 주사제: Glucagon-Like Peptide-1 수용체작용제: Inkuk Lee, Eun Seok Kang; J Korean Diabetes. 2019;20(3):149-156. Published online October 2, 2019; DOI: https://doi.org/10.4093/jkd.2019.20.3.149

Sodium-Glucose Cotransporter 2 억제제의 심혈관 질환 예방 효과 유발 기전: Jae Han Jeon; J Korean Diabetes. 2019;20(2):81-86. Published online July 17, 2019; DOI: https://doi.org/10.4093/jkd.2019.20.2.81

Statement

제2형 당뇨병 환자의 혈당 관리: 2018년 미국/유럽 당뇨병학회 합의안 요약: Jeong Mi Kim, Sang Soo Kim; J Korean Diabetes. 2019;20(1):6-9. Published online April 4, 2019; DOI: https://doi.org/10.4093/jkd.2019.20.1.6

Opinion

관찰연구에서 확인된 SGLT2 억제제의 심혈관질환 예방효과: 한국인의 결과를 중심으로: Kyoung Hwa Ha, Dae Jung Kim; J Korean Diabetes. 2018;19(3):135-139. Published online October 5, 2018; DOI: https://doi.org/10.4093/jkd.2018.19.3.135

2018년 미국당뇨병학회 진료지침 속의 작지만 큰 변화: Jeong Hyun Park; J Korean Diabetes. 2018;19(2):71-75. Published online July 9, 2018; DOI: https://doi.org/10.4093/jkd.2018.19.2.71

Focused Issues

제2형 당뇨병 약제치료 지침 2017 개정안: Glucagon-Like Peptide-1 수용체작용제: Hyun Jin Kim; J Korean Diabetes. 2018;19(1):35-40. Published online April 13, 2018; DOI: https://doi.org/10.4093/jkd.2018.19.1.35

Statement

당뇨병 환자에게 적절한 목표 혈압: Tae Soo Kang, Sungha Park; J Korean Diabetes. 2018;19(1):7-14. Published online April 13, 2018; DOI: https://doi.org/10.4093/jkd.2018.19.1.7

제2형 당뇨병 환자에서 진행된 대규모 심혈관 임상시험이 주는 교훈: Nam Hoon Kim, Sin Gon Kim; J Korean Diabetes. 2017;18(1):7-13. Published online April 3, 2017; DOI: https://doi.org/10.4093/jkd.2017.18.1.7

Volume 22, No. 3

The Journal of
Korean Diabetes

Print ISSN: 2233-7431
Online ISSN: 2714-0547

MOST VIEWED

7,318	COVID-19, Home Training for Patients with Diabetes Mellitus
4,082	Recent Guideline for the Management of Dyslipidemia in Patients with Diabetes
1,131	Diabetes and Vitamin D
875	Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease: Diagnosis and Treatment
852	Diabetes and Heart Failure

Editorial Office: 101-2104, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-714-9064 Fax: +82-2-714-9084 E-mail: diabetes@kams.or.kr

Copyright © 2021 by Korean Diabetes Association. All rights reserved.